Why the study?
Does streptokinase treatment for deep vein thrombosis trigger cholesterol crystal embolization from aortic atheromas?
Does streptokinase treatment for deep vein thrombosis trigger cholesterol crystal embolization from aortic atheromas?
Streptokinase therapy may trigger cholesterol crystal embolization by lysing protective thrombi over aortic atheromas.
Streptokinase may trigger cholesterol embolization in patients with aortic atheromas; this case report leaves open causality and clinical relevance.
To the Editor.— In a recent article (241:807, 1979), Kempczinski described lower extremity arterial emboli from ulcerating atherosclerotic plaques. Neither heparin nor warfarin had been effective in preventing recurrent embolization.¹⁻³ We observed a 65-year-old man in whom, two days after initiation of treatment of bilateral femoral vein thrombosis with streptokinase, livedo reticularis of the lower part of the body developed; a few days later, necrosis of skin and toes and acute renal failure developed. The renal failure was treated conservatively; for several reasons, hemodialysis was not performed. At autopsy, severe ulcerative atheromatosis of the aorta with cholesterol crystal embolization (CCE) in both kidneys was found (Figure), as well as in the liver, spleen, prostate, and medium-sized and small femoral arteries. The time course and the finding of CCE in only the lower part of the body may suggest a lysis of the protecting thrombi from the aortic atheromas by
No takes yet. Share an insight, caveat, or question.
P. Oster (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: